AAPM&R Annual Assembly 2019 Archives - Page 4 of 57

A Resident-Managed Quality Improvement Project Tracking Spine Conditions Using Functional Outcome Measures to Track Episodes of Cares for Merit Incentive Payment System Requirements (MIPS)
Marc P. Gruner, DO, MBA, RMSK (Medstar Health/Georgetown-National Rehabilitation Hospital PM&R Program, Washington, DC, United States); John Taylor Mansfied, DO; Nolan Gall, MD; Matthew Maxwell, MD, CAQSM, FAAPMR
A Retrospective Study Evaluating Risks Associated with Musculoskeletal Corticosteroid Injections in Patients with Diabetes
Kristyn Williams (University of Texas Southwestern Medical Center, Dallas, TX, United States); Lindsay Ramey, MD
A Symptomatic Schmorl’s Node in a Young Man. An Unusual Cause of Back Pain in a Teen: A Case Report
Nivin Porwal, DO (Detroit Medical Center/Wayne State University PM&R Program, Detroit, MI, United States); Steven Arbit, MD; Evan Arbit
A Systematic Review of the Standard of Care, Treatments, and Rehabilitation Approaches for Sports Related Concussion
Lauren N. Neuman, DO, MBA (University of Kansas School of Medicine PM&R Program, Kansas City, KS, United States); Bradley Schuessler; David H. Sherwood, DO; Michael Carroll; John C. Alm
A Toddler Diagnosed with Trisomy 14 Mosaicism with Sacrococcygeal Osseous Deformities: A Case Report
Matthew A. Erby, MD (New York Presbyterian Hospital (Columbia and Cornell) PM&R Program, New York, NY, United States); Frank Schirripa, DO; Monika Desai, MD
A Unique Case of Intrapleural Neurolysis for Brachial Plexus Cancer Pain
Marine Dididze, MD, PhD (Jackson Memorial Hospital/Jackson Health System PM&R Program, Miami, FL, United States); Loel Warsch; Dennis Patin
A Unique Case of Polyneuropathy Unmasked by Post-surgical Edema: A Case Report
Jason B. Coombs, DO (Mary Free Bed Hospital PM&R Program, Jenison, United States)
AbobotulinumtoxinA Improves Functional Outcomes After Single and Repeat Dosing in Adults and Children with Spasticity
Alberto Esquenazi, MD, FAAPMR (MossRehab Gait and Motion Analysis Laboratory, Elkins Park, PA, United States); Jean-Michel Gracies; Philippe Picaut; Anne-Sophie Grandoulier; Mauricio Delgado
AbobotulinumtoxinA Using 2 mL Dilution Maintain Durable Functional Improvements Across Multiple Treatment Cycles
Khashayar Dashtipour, MD, PhD (Loma Linda University School of Medicine, CA, United States); Laxman Bahroo; Daniel Truong; Richard Trosch; Pascal Maisonobe; Stefan Wietek
AbobotulinumtoxinA: Evidence for Long Duration of Response
Keith A Foster, FRSB (Ipsen Bioinnovation, Abingdon, England, United Kingdom); Andreas Lysandropoulos; Philippe Picaut